Related Experiment Video
Updated: May 22, 2025
11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.4K
Hypoxia Modulates Transmembrane Prostatic Acid Phosphatase (TM-PAP) in MCF-7 Breast Cancer Cells
Marco Antonio Lacerda-Abreu1, Luiz Fernando Carvalho-Kelly1, José Roberto Meyer-Fernandes1
1Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-901, Brazil.
International Journal of Molecular Sciences
|March 13, 2025
Summary
Hypoxia significantly reduces transmembrane prostatic acid phosphatase (TM-PAP) ectophosphatase activity in breast cancer cells by increasing reactive oxygen species (ROS) and activating protein kinase C (PKC). This impacts tumor progression and offers therapeutic targets.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Transmembrane prostatic acid phosphatase (TM-PAP) is crucial for tumor progression, especially in hypoxic environments.
- Hypoxia significantly impacts the tumor microenvironment and cellular functions.
Purpose of the Study:
- To investigate the effect of hypoxia on ectophosphatase activity in MCF-7 breast cancer cells.
- To explore the biological mechanisms linking hypoxia, TM-PAP activity, and breast cancer progression.
Main Methods:
- Assessing ectophosphatase activity under normoxic and hypoxic conditions.
- Measuring substrate hydrolysis (pNPP, AMP) and reactive oxygen species (ROS) levels.
- Investigating the role of ROS scavengers and protein kinase C (PKC) activation.
Main Results:
- Hypoxia significantly reduced ectophosphatase activity in MCF-7 cells compared to normoxic conditions.
- Hypoxia increased ROS production (H2O2), inhibiting TM-PAP activity, an effect reversed by ROS scavengers.
- Hypoxia activated PKC, further modulating ectophosphatase activity.
Conclusions:
- Hypoxia impairs TM-PAP-mediated dephosphorylation crucial for tumor growth and metastasis.
- ROS generation and PKC activation are key mechanisms mediating hypoxia's effect on TM-PAP.
- Findings offer insights for developing targeted therapies against hypoxic breast cancer.
